Brief: Eckert & Ziegler - Pentixapharm Holding AG, A Subsidiary Of Eckert & Ziegler SE, Plans IPO On Prime Standard Of Frankfurt Stock Exchange

Eckert & Ziegler SE

12/09/2024 14:09

Sept 12 (Reuters) - Eckert & Ziegler SE  EUZG.DE :
    * PENTIXAPHARM HOLDING AG, A SUBSIDIARY OF ECKERT & ZIEGLER
SE,
PLANS IPO ON PRIME STANDARD OF FRANKFURT STOCK EXCHANGE
    * ECKERT & ZIEGLER - PENTIXAPHARM IPO STRATEGIC STEP TO
SECURE
SHORT- AND LONG-TERM FINANCING
    * GOAL OF LISTING IN Q4 OF 2024
    * PENTIXAPHARM PLANS TO INITIATE A PHASE III REGISTRATION
TRIAL IN
UNITED STATES FOR ITS MOST ADVANCED DEVELOPMENT CANDIDATE,
PENTIXAFOR, IN INDICATION OF PRIMARY ALDOSTERONISM (PA)

Source text for Eikon:  ID:nEQc8C45ka 
Further company coverage:  EUZG.DE 

 (Gdansk Newsroom)
 (((( gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));))